InsiderTrades.com logo
Carl L. Gordon net worth and biography
  • LinkedIn

Carl Gordon Biography and Net Worth

Director of BlossomHill Therapeutics

Carl L. Gordon, Ph.D., CFA, is a managing partner at OrbiMed Advisors LLC, an investment firm. Dr. Gordon has served on the board of directors of Compass Therapeutics Inc., a publicly held biopharmaceutical company, since September 2015, as well as several other privately held companies. He received a Bachelor of Arts in chemistry from Harvard College, a doctorate in molecular biology from the Massachusetts Institute of Technology and was a fellow at The Rockefeller University.

What is Carl L. Gordon's net worth?

The estimated net worth of Carl L. Gordon is at least $43.75 million as of August 10th, 2026. Dr. Gordon owns 2,714,279 shares of BlossomHill Therapeutics stock worth more than $43,754,177 as of August 21st. This net worth approximation does not reflect any other investments that Dr. Gordon may own. Learn More about Carl L. Gordon's net worth.

How do I contact Carl L. Gordon?

The corporate mailing address for Dr. Gordon and other BlossomHill Therapeutics executives is , ,. Learn More on Carl L. Gordon's contact information.

Has Carl L. Gordon been buying or selling shares of BlossomHill Therapeutics?

During the last ninety days, Carl L. Gordon has bought $10,000,000.00 in BlossomHill Therapeutics stock. Most recently, on Monday, August 10th, Carl L. Gordon bought 625,000 shares of BlossomHill Therapeutics stock. The stock was acquired at an average cost of $16.00 per share, with a total value of $10,000,000.00. Following the completion of the transaction, the director now directly owns 2,714,279 shares of the company's stock, valued at $43,428,464. Learn More on Carl L. Gordon's trading history.

Who are BlossomHill Therapeutics' active insiders?

BlossomHill Therapeutics' insider roster includes Bihua Chen (Director), and Carl Gordon (Director). Learn More on BlossomHill Therapeutics' active insiders.

Are insiders buying or selling shares of BlossomHill Therapeutics?

In the last year, BlossomHill Therapeutics insiders bought shares 7 times. They purchased a total of 1,573,900 shares worth more than $25,181,900.00. The most recent insider tranaction occured on August, 10th when Director John P Schmid bought 6,000 shares worth more than $96,000.00. Learn More about insider trades at BlossomHill Therapeutics.

Information on this page was last updated on 8/10/2026.

Carl L. Gordon Insider Trading History at BlossomHill Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2026Buy625,000$16.00$10,000,000.002,714,279View SEC Filing Icon  
See Full Table

Carl L. Gordon Buying and Selling Activity at BlossomHill Therapeutics

This chart shows Carl L Gordon's buying and selling at BlossomHill Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BlossomHill Therapeutics Company Overview

BlossomHill Therapeutics logo
BlossomHill Therapeutics Inc. is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop small molecule medicines which address significant unmet medical needs in cancer treatment. The company's lead clinical programs include BH-30643. BlossomHill Therapeutics Inc. is headquartered in San Diego, California.
Read More

Today's Range

Now: $16.11
Low: $15.75
High: $16.50

50 Day Range

MA: N/A

2 Week Range

Now: $16.11
Low: $15.25
High: $17.25

Volume

39,232 shs

Average Volume

286,258 shs

Market Capitalization

$493.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A